Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Gonda

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Antimicrobial Agents and Chemotherapy|July 18, 2018
Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal CiprofloxacinJames D Blanchard, Valerie Elias, David Cipolla, et al.
Pharmaceutical Research|July 22, 2016
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline DrugDavid Cipolla, Huiying Wu, Simon Eastman, et al.
Journal of Pharmaceutical Sciences|April 10, 2014
Modifying the release properties of liposomes toward personalized medicineDavid Cipolla, Huiying Wu, Igor Gonda, et al.
Pulmonary Therapy|September 10, 2025
Impact of Flow Restrictors on Aerosol Delivery of the Respimat® Soft Mist InhalerMoritz Fleischhauer, Kai Berkenfeld, David Stadermann, et al.
Pharmaceutical Research|July 27, 2012
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epitheliaHui Xin Ong, Daniela Traini, David Cipolla, et al.
Frontiers in Cellular and Infection Microbiology|May 18, 2026
Immunological changes associated with the treatment of pneumonic tularaemia in marmosetsRachel E Ireland, Alejandro Nunez, James D Blanchard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2013
In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisationHui Xin Ong, Faiza Benaouda, Daniela Traini, et al.
AAPS Pharmsci|November 9, 2002
Aerosolization of lipoplexes using AERx Pulmonary Delivery SystemDeepa Deshpande, James Blanchard, Sudarshan Srinivasan, et al.
The European Respiratory Journal|June 20, 2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studiesJames D Chalmers, David Cipolla, Bruce Thompson, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|March 3, 2005
Gamma scintigraphic evaluation of a miniaturized AERx pulmonary delivery system for aerosol delivery to anesthetized animals using a positive pressure ventilation systemDeepa S Deshpande, James D Blanchard, Jeffrey Schuster, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|July 18, 2018
Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal CiprofloxacinJames D Blanchard, Valerie Elias, David Cipolla, et al.
Pharmaceutical Research|July 22, 2016
Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline DrugDavid Cipolla, Huiying Wu, Simon Eastman, et al.
Journal of Pharmaceutical Sciences|April 10, 2014
Modifying the release properties of liposomes toward personalized medicineDavid Cipolla, Huiying Wu, Igor Gonda, et al.
Pulmonary Therapy|September 10, 2025
Impact of Flow Restrictors on Aerosol Delivery of the Respimat® Soft Mist InhalerMoritz Fleischhauer, Kai Berkenfeld, David Stadermann, et al.
Pharmaceutical Research|July 27, 2012
Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epitheliaHui Xin Ong, Daniela Traini, David Cipolla, et al.
Frontiers in Cellular and Infection Microbiology|May 18, 2026
Immunological changes associated with the treatment of pneumonic tularaemia in marmosetsRachel E Ireland, Alejandro Nunez, James D Blanchard, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2013
In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisationHui Xin Ong, Faiza Benaouda, Daniela Traini, et al.
AAPS Pharmsci|November 9, 2002
Aerosolization of lipoplexes using AERx Pulmonary Delivery SystemDeepa Deshpande, James Blanchard, Sudarshan Srinivasan, et al.
The European Respiratory Journal|June 20, 2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studiesJames D Chalmers, David Cipolla, Bruce Thompson, et al.
Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine|March 3, 2005
Gamma scintigraphic evaluation of a miniaturized AERx pulmonary delivery system for aerosol delivery to anesthetized animals using a positive pressure ventilation systemDeepa S Deshpande, James D Blanchard, Jeffrey Schuster, et al.
Pageof 4